Creative Medical Technology Holdings, Inc. Debt Instrument, Fee Amount
Creative Medical Technology Holdings, Inc. (CELZ) had Debt Instrument, Fee Amount of $30.13 thousand as of 2018-08-08, per its 10-Q filed 2018-11-14.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFeeAmount · last filed 2018-11-14
- 2018-08-08: Debt Instrument, Fee Amount $30.13K.
| Period end | Debt Instrument, Fee Amount |
|---|---|
| 2018-08-08 | $30.13K 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |